These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 18413157

  • 1. The kidney expression of matrix metalloproteinase-9 in the diabetic nephropathy of Kkay mice.
    Qing-Hua G, Ju-Ming L, Chang-Yu P, Zhao-Hui L, Xiao-Man Z, Yi-Ming M.
    J Diabetes Complications; 2008; 22(6):408-12. PubMed ID: 18413157
    [Abstract] [Full Text] [Related]

  • 2. Effects of benazepril on renal function and kidney expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 in diabetic rats.
    Sun SZ, Wang Y, Li Q, Tian YJ, Liu MH, Yu YH.
    Chin Med J (Engl); 2006 May 20; 119(10):814-21. PubMed ID: 16732983
    [Abstract] [Full Text] [Related]

  • 3. [The mechanism of homocysteine in Kkay mice diabetic nephropathy model].
    Lu JM, Guo QH, Pan CY, Mu YM, Zou XM, Yin L, Sheng CY.
    Zhonghua Nei Ke Za Zhi; 2004 Aug 20; 43(8):604-7. PubMed ID: 15355667
    [Abstract] [Full Text] [Related]

  • 4. Eicosapentaenoic acid ameliorates diabetic nephropathy of type 2 diabetic KKAy/Ta mice: involvement of MCP-1 suppression and decreased ERK1/2 and p38 phosphorylation.
    Hagiwara S, Makita Y, Gu L, Tanimoto M, Zhang M, Nakamura S, Kaneko S, Itoh T, Gohda T, Horikoshi S, Tomino Y.
    Nephrol Dial Transplant; 2006 Mar 20; 21(3):605-15. PubMed ID: 16282336
    [Abstract] [Full Text] [Related]

  • 5. Effects of pioglitazone on expressions of matrix metalloproteinases 2 and 9 in kidneys of diabetic rats.
    Dong FQ, Li H, Cai WM, Tao J, Li Q, Ruan Y, Zheng FP, Zhang Z.
    Chin Med J (Engl); 2004 Jul 20; 117(7):1040-4. PubMed ID: 15265379
    [Abstract] [Full Text] [Related]

  • 6. Effect of angiotensin II receptor blocker on glucose-induced mRNA expressions of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in rat mesangial cells.
    Ding HL, Guo Y, Xu MT, Li HY, Fu ZZ.
    Chin Med J (Engl); 2007 Nov 05; 120(21):1886-9. PubMed ID: 18067760
    [Abstract] [Full Text] [Related]

  • 7. [Expression of plasminogen activator inhibitor-1 and tissue plasminogen activator in the kidney of KKAy mice with type 2 diabetes].
    Chen LM, Li XW, Huang LW, Li Y.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Jun 05; 27(3):344-8. PubMed ID: 16038272
    [Abstract] [Full Text] [Related]

  • 8. Lack of {alpha}8-integrin aggravates podocyte injury in experimental diabetic nephropathy.
    Hartner A, Cordasic N, Menendez-Castro C, Volkert G, Yabu JM, Kupraszewicz-Hutzler M, Rascher W, Hilgers KF.
    Am J Physiol Renal Physiol; 2010 Nov 05; 299(5):F1151-7. PubMed ID: 20826576
    [Abstract] [Full Text] [Related]

  • 9. Experimental diabetic nephropathy is accelerated in matrix metalloproteinase-2 knockout mice.
    Takamiya Y, Fukami K, Yamagishi S, Kaida Y, Nakayama Y, Obara N, Iwatani R, Ando R, Koike K, Matsui T, Nishino Y, Ueda S, Cooper ME, Okuda S.
    Nephrol Dial Transplant; 2013 Jan 05; 28(1):55-62. PubMed ID: 23028104
    [Abstract] [Full Text] [Related]

  • 10. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM.
    Del Prete D, Anglani F, Forino M, Ceol M, Fioretto P, Nosadini R, Baggio B, Gambaro G.
    Diabetologia; 1997 Dec 05; 40(12):1449-54. PubMed ID: 9447953
    [Abstract] [Full Text] [Related]

  • 11. [The effects of TCM Yishen Decoction on the expression of MMP-9 and TIMP-1 in kidney of mouse with IgA nephropathy].
    Wan QJ, He YC, Shi CG, Hong GB, Hu B, Luan SD.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2007 Jul 05; 23(7):633-4. PubMed ID: 17618586
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Effects of puerarin on renal function, expressions of MMP-2 and TIMP-2 in diabetic rats].
    Duan HJ, Liu SX, Zhang YJ, Liu QJ, He N, Li YM.
    Yao Xue Xue Bao; 2004 Jul 05; 39(7):481-5. PubMed ID: 15493832
    [Abstract] [Full Text] [Related]

  • 14. Analysis of NO-synthase expression and clinical risk factors in human diabetic nephropathy.
    Hohenstein B, Hugo CP, Hausknecht B, Boehmer KP, Riess RH, Schmieder RE.
    Nephrol Dial Transplant; 2008 Apr 05; 23(4):1346-54. PubMed ID: 18065828
    [Abstract] [Full Text] [Related]

  • 15. Discrepancy between intrarenal messenger RNA and protein expression of ACE and ACE2 in human diabetic nephropathy.
    Wang G, Lai FM, Lai KB, Chow KM, Kwan CH, Li KT, Szeto CC.
    Am J Nephrol; 2009 Apr 05; 29(6):524-31. PubMed ID: 19077419
    [Abstract] [Full Text] [Related]

  • 16. Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo.
    Daniel C, Schaub K, Amann K, Lawler J, Hugo C.
    Diabetes; 2007 Dec 05; 56(12):2982-9. PubMed ID: 17878288
    [Abstract] [Full Text] [Related]

  • 17. The role of renal aquaporin 2 in the alleviation of dehydration associated with diabetic polyuria in KKAy mice.
    Satake M, Ikarashi N, Ichikawa Y, Maniwa A, Toda T, Ito K, Ochiai W, Sugiyama K.
    Life Sci; 2010 Oct 09; 87(15-16):475-80. PubMed ID: 20832413
    [Abstract] [Full Text] [Related]

  • 18. Isosteviol increases insulin sensitivity and changes gene expression of key insulin regulatory genes and transcription factors in islets of the diabetic KKAy mouse.
    Nordentoft I, Jeppesen PB, Hong J, Abudula R, Hermansen K.
    Diabetes Obes Metab; 2008 Sep 09; 10(10):939-49. PubMed ID: 18201205
    [Abstract] [Full Text] [Related]

  • 19. The influence of type I diabetes mellitus on the expression and activity of gelatinases (matrix metalloproteinases-2 and -9) in induced periodontal disease.
    Silva JA, Lorencini M, Peroni LA, De La Hoz CL, Carvalho HF, Stach-Machado DR.
    J Periodontal Res; 2008 Feb 09; 43(1):48-54. PubMed ID: 18230106
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.